The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has substantially damaged the global economy and human health. The …

Evolution of SARS-CoV-2 requires the reassessment of current vaccine measures. Here, we
characterized BA. 2.86 and XBB-derived variant FLip by investigating their neutralization …

We investigate JN. 1-derived subvariants SLip, FLiRT, and KP. 2 for neutralization by
antibodies in vaccinated individuals, severe acute respiratory syndrome coronavirus 2 …

Immune evasion by SARS-CoV-2 paired with immune imprinting from monovalent mRNA
vaccines has resulted in attenuated neutralizing antibody responses against Omicron …

ABSTRACT The highly mutated BA. 2.86, with over 30 spike protein mutations in
comparison to Omicron BA. 2 and XBB. 1.5 variants, has raised concerns about its potential …

Summary BA. 2.86, a recently identified descendant of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) Omicron BA. 2 sublineage, contains∼ 35 mutations …

Understanding the longitudinal dynamics of antibody immunity following heterologous SAR-
CoV-2 breakthrough infection will inform the development of next-generation vaccines …

Evolution of SARS-CoV-2 requires the reassessment of current vaccine measures. Here, we
characterized BA. 2.86 and the XBB-lineage variant FLip by investigating their neutralization …

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues
to challenge the efficacy of vaccination efforts against coronavirus disease 2019 (COVID …